{"org_id": "T004433311", "org_name_cn": "江苏艾迪药业股份有限公司", "org_short_name_cn": "艾迪药业", "org_name_en": "Jiangsu Aidea Pharmaceutical Co.,Ltd.", "org_short_name_en": "Aidea Pharma", "main_operation_business": "探索、研发和销售创新性化学药物以及人源蛋白产品。", "operating_scope": "　　药品研发、药品生产和销售；人尿蛋白、动物脏器和植物原料有效成分的开发、收购、加工与销售；技术研究开发与转让、技术咨询和技术服务；自营和代理一般商品及技术的进出口业务（不涉及国营贸易管理商品，涉及配额、许可证管理商品的按国家有关规定办理申请）。（经营范围不含国家实施外商投资准入特别管理措施的项目，依法须经批准的项目，经相关部门批准后方可开展经营活动）", "district_encode": "321003", "org_cn_introduction": "江苏艾迪药业股份有限公司主营业务为致力于探索、研发和销售创新性化学药物以及人源蛋白产品。主要产品有乌司他丁、尤瑞克林、尿激酶等人源蛋白产品以及蜡样芽孢杆菌片、番泻叶颗粒、头孢拉定胶囊等制剂。公司核心团队稳定,曾先后承担了六项国家级重大科技专项、产业化项目,以及多项省、市级科技项目。", "legal_representative": "傅和亮", "general_manager": "傅和亮", "secretary": "王广蓉", "established_date": 1260806400000, "reg_asset": 420000000.0, "staff_num": 396, "telephone": "86-514-82090238", "postcode": "225008", "fax": "86-514-87736366", "email": "ad@aidea.com.cn", "org_website": "www.aidea.com.cn", "reg_address_cn": "江苏省扬州市邗江区刘庄路2号", "reg_address_en": "", "office_address_cn": "江苏省扬州市邗江区新甘泉西路69号", "office_address_en": "", "currency_encode": "019001", "currency": "CNY", "listed_date": 1595174400000, "provincial_name": "江苏省", "actual_controller": "Jindi Wu (22.36%)，傅和亮 (21.04%)", "classi_name": "民营企业", "pre_name_cn": "江苏艾迪药业有限公司", "chairman": "傅和亮", "executives_nums": 15, "actual_issue_vol": 60000000.0, "issue_price": 13.99, "actual_rc_net_amt": 764070000.0, "pe_after_issuing": 285.07, "online_success_rate_of_issue": 0.04014192, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}